Cargando…
Preimplantation genetic diagnosis for retinoblastoma survivors: a cost-effectiveness study
This study aimed to investigate the cost-effectiveness of preimplantation genetic diagnosis (PGD) for the reproductive choices of patients with heritable retinoblastoma. The study modelled the costs of three cycles of in-vitro fertilization (IVF) and PGD across all uptake rates of PGD, number of chi...
Autores principales: | Schofield, D., Zeppel, M.J.B., Staffieri, S., Shrestha, R.N., Jelovic, D., Lee, E., Jamieson, R.V. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7301166/ https://www.ncbi.nlm.nih.gov/pubmed/32577540 http://dx.doi.org/10.1016/j.rbms.2020.03.001 |
Ejemplares similares
-
Practices and ethical concerns regarding preimplantation diagnosis. Who
regulates preimplantation genetic diagnosis in Brazil?
por: Damian, B.B., et al.
Publicado: (2014) -
Reprogenetics: Preimplantational genetics diagnosis
por: Coco, Roberto
Publicado: (2014) -
Danish heritable retinoblastoma survivors' perspectives on reproductive choices: “It's important for me, not to pass on this condition”
por: Gregersen, Pernille A., et al.
Publicado: (2022) -
Preimplantation genetic diagnosis in Saudi Arabia
por: Abotalib, Zeinab
Publicado: (2013) -
Preimplantation Genetic Diagnosis in Marfan Syndrome
por: Vlahos, N. F., et al.
Publicado: (2013)